These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6411920)

  • 1. High dose, low frequency parenteral gold administration.
    Norton WL; Donnelly RJ
    J Rheumatol; 1983 Jun; 10(3):454-8. PubMed ID: 6411920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aurothioglucose in rheumatoid arthritis. Outcome of treatment in patients intolerant of sodium aurothiomalate.
    McGirr EE; Browne CD; Champion GD; Day RO; Sambrook PN
    Med J Aust; 1984 Sep; 141(6):349-51. PubMed ID: 6438454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
    Rau R; Schleusser B; Herborn G; Karger T
    J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gold treatment of progressive chronic polyarthritis--a clinical study].
    Knoche U; Wagner H; Hauss WH
    Z Rheumatol; 1975; 34(5-6):203-12. PubMed ID: 779340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Follow-up studies of patients suffering from rheumatoid arthritis and treated with gold].
    de Blécourt JJ; de Boer JP; Hofman D; Vorenkamp EO
    Ned Tijdschr Geneeskd; 1978 Nov; 122(47):1841-3. PubMed ID: 362221
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of auranofin dose regimen change upon cell-associated gold in rheumatoid arthritic patients.
    Walz DT; Griswold DE; DiMartino MJ; Bumbier EE
    J Rheumatol; 1981; 8(5):829-32. PubMed ID: 6796684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of chronic polyarthritis with low-dose methotrexate].
    Karger T; Rau R
    Dtsch Med Wochenschr; 1988 May; 113(21):839-46. PubMed ID: 3371211
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Auranofin treatment for adult rheumatoid arthritis. Comparison of 2 mg and 6 mg daily dose.
    Bernhard GC
    J Rheumatol Suppl; 1982; 8():149-53. PubMed ID: 6813477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral chrysotherapy in rheumatoid arthritis: minimum effective dose.
    Finkelstein AE; Roisman FR; Batista V; de Nudelman FG; de Titto EH; Mizraji M; Walz DT
    J Rheumatol; 1980; 7(2):160-8. PubMed ID: 6768887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of auranofin compared to placebo in rheumatoid arthritis.
    Katz WA; Alexander S; Bland JH; Blechman W; Bluhm GB; Bonebrake RA; Falbo A; Greenwald RA; Hartman S; Hobbs T; Indenbaum S; Lergier JE; Lanier BG; Lightfoot RW; Phelps P; Sheon RP; Torretti D; Wenger ME; Wilske K
    J Rheumatol Suppl; 1982; 8():173-8. PubMed ID: 6813481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Experiences to date with oral gold therapy].
    Zeidler H
    Wien Klin Wochenschr Suppl; 1984; 156():22-7. PubMed ID: 6442052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Preliminary results of oral gold treatment with auranofin following lack of success of intramuscular gold therapy].
    Rainer F; Ulreich A
    Wien Klin Wochenschr Suppl; 1984; 156():49-51. PubMed ID: 6442058
    [No Abstract]   [Full Text] [Related]  

  • 13. Meta-analysis of injectable gold in rheumatoid arthritis.
    Clark P; Tugwell P; Bennett K; Bombardier C
    J Rheumatol; 1989 Apr; 16(4):442-7. PubMed ID: 2664167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single dose pharmacokinetics of auranofin in rheumatoid arthritis.
    Blocka K; Furst DE; Landaw E; Dromgoole S; Blomberg A; Paulus HE
    J Rheumatol Suppl; 1982; 8():110-9. PubMed ID: 6813473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Auranofin: 1 mg or 9 mg? The search for the appropriate dose.
    Calin A; Saunders D; Bennett R; Jacox R; Kaplan D; O'Brien W; Paulus HE; Roth S; Weiss T
    J Rheumatol Suppl; 1982; 8():146-8. PubMed ID: 6813476
    [No Abstract]   [Full Text] [Related]  

  • 16. Management of pemphigus with gold compounds: a long-term follow-up report.
    Penneys NS; Eaglstein WH; Frost P
    Arch Dermatol; 1976 Feb; 112(2):185-7. PubMed ID: 822783
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose aurothioglucose in pemphigus vulgaris.
    Frumkin A
    Isr J Med Sci; 1986 Dec; 22(12):903-5. PubMed ID: 3106259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A multicentre controlled trial of the effects of different dosage of gold therapy, followed by a maintenance dosage.
    Cats A
    Agents Actions; 1976 Feb; 6(1-3):355-63. PubMed ID: 133601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [FDDF (fast dissolving dosage form) piroxicam for sublingual administration in the treatment of rheumatoid arthritis].
    Montecucco C; Caporali R; Ronchetti A; Rossi S; Comaschi E
    Minerva Med; 1994 Dec; 85(12):633-8. PubMed ID: 7854556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of actarit combination therapy in patients with active rheumatoid arthritis resistant to gold agents].
    Sakurai T; Iso T; Inoue H; Sano K; Takeuchi K; Takagishi K
    Ryumachi; 2001 Jun; 41(3):635-45. PubMed ID: 11505513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.